Abstract
The naturally occurring dipterpene molecule Phytol is an alcohol that can be extracted from the chlorophyll of green plants. Phytol has been studied for decades and has been suggested to have both metabolic properties as well as potent anti-inflammatory effects. Phytol represents a molecule derived by nature with lipid regulating properties, in line with today’s need for new drugs to control for diseases that follow the westernized diet and life style. The beneficial effects of phytol on health is in this chapter presented as one interesting naturally derived component in new natural remedies and functional food products to tackle the rapidly increasing global health problems caused by cardiovascular and chronic inflammatory diseases.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Allen NE, Grace PB, Ginn A, Travis RC, Roddam AW, Appleby PN, Key T (2008) Phytanic acid: measurement of plasma concentrations by gas–liquid chromatography–mass spectrometry analysis and associations with diet and other plasma fatty acids. Brit J Nutr 99(3):653–659
Baxter JH (1968) Absorption of chlorophyll phytol in normal man and in patients with refsum’s disease. J Lipid Res 9(5):636–641
Baxter JH, Steinber D (1967) Absorption of phytol from dietary chlorophyll in rat. J Lipid Res 8(6):615–620
Baxter JH, Steinberg D, Mize CE, Avigan J (1967) Absorption and metabolism of uniformly 14C-labeled phytol and phytanic acid by the intestine of the rat studied with thoracic duct cannulation. Biochim Biophys Acta 137(2):277–290
Chowdhury RR, Ghosh SK (2012) Phytol-derived novel isoprenoid immunostimulants. Front Immunol 3:49
Costa JP, Ferreira PB, De Sousa DP, Jordan J, Freitas RM (2012) Anticonvulsant effect of phytol in a pilocarpine model in mice. Neurosci Lett 523(2):115–118
Daudin JB, Monnet D, Kavian N, Espy C, Wang A, Chereau C, Goulvestre C, Omri S, Brezin A, Weill B, Batteux F, Nicco C (2011) Protective effect of pristane on experimental autoimmune uveitis. Immunol Lett 141(1):83–93
Ellinghaus P, Wolfrum C, Assmann G, Spener F, Seedorf U (1999) Phytanic acid activates the peroxisome proliferator-activated receptor alpha (PPAR alpha) in sterol carrier protein 2-/ sterol carrier protein x-deficient mice. J Biol Chem 274(5):2766–2772
Gelderman KA, Hultqvist M, Olsson LM, Bauer K, Pizzolla A, Olofsson P, Holmdahl R (2007) Rheumatoid arthritis: the role of reactive oxygen species in disease development and therapeutic strategies. Antioxid Redox Signal 9(10):1541–1567
Gloerich J, van den Brink DM, Ruiter JPN, van Vlies N, Vaz FM, Wanders RJA, Ferdinandusse S (2007) Metabolism of phytol to phytanic acid in the mouse, and the role of PPAR alpha in its regulation. J Lipid Res 48(1):77–85
Gloerich J, van Vlies N, Jansen GA, Denis S, Ruiter JPN, van Werkhoven MA, Duran M, Vaz FM, Wanders RJA, Ferdinandusse S (2005) A phytol-enriched diet induces changes in fatty acid metabolism in mice both via PPAR alpha-dependent and -independent pathways. J Lipid Res 46(4):716–726
Goto T, Takahashi N, Kato S, Egawa K, Ebisu S, Moriyama T, Fushiki T, Kawada T (2005) Phytol directly activates peroxisome proliferator-activated receptor alpha (PPAR alpha) and regulates gene expression involved in lipid metabolism in PPAR alpha-expressing HepG2 hepatocytes. Biochem biophys res commun 337(2):440–445
Gremese E, Ferraccioli G (2011) The metabolic syndrome: the crossroads between rheumatoid arthritis and cardiovascular risk. Autoimmun Rev 10(10):582–589
Hashimoto T, Shimizu N, Kimura T, Takahashi Y, Ide T (2006) Polyunsaturated fats attenuate the dietary phytol-induced increase in hepatic fatty acid oxidation in mice. J Nutr 136(4):882–886
Heidenreich PA, Trogdon JG, Khavjou OA, Butler J, Dracup K, Ezekowitz MD, Finkelstein EA, Hong YL, Johnston SC, Khera A, Lloyd-Jones DM, Nelson SA, Nichol G, Orenstein D, Wilson PWF, Woo YJ, Coordina AHAA, Council S, Inter CCR, Cardiology CC, Prevention CE, Thrombosi CA, C CCC, Nursing CC, Dis CKC, Anesthe CCS, Quality IC (2011) Forecasting the future of cardiovascular disease in the United States a policy statement from the american heart association. Circulation 123(8):933–944
Heim M, Johnson J, Boess F, Bendik I, Weber P, Hunziker W, Fluhmann B (2002) Phytanic acid, a natural peroxisome proliferator-activated receptor agonist, regulates glucose metabolism in rat primary hepatocytes. Faseb J 16(3):718–720
Hellgren LI (2010) Phytanic acid-an overlooked bioactive fatty acid in dairy fat? Ann Ny Acad Sci 1190:42–49
Hidiroglou M, Jenkins KJ (1972) Effect of phytol on the incidence of muscular dystrophy in rabbits. Can J Physiol Pharmacol 50(2):171–172
Holmberg J, Tuncel J, Yamada H, Lu S, Olofsson P, Holmdahl R (2006) Pristane, a non-antigenic adjuvant, induces MHC class II-restricted, arthritogenic T cells in the rat. J Immunol 176(2):1172–1179
Hultqvist M, Olofsson P, Gelderman KA, Holmberg J, Holmdahl R (2006) A new arthritis therapy with oxidative burst inducers. PLoS Med 3(9):e348
Kahlke W, Wagener H (1966) Conversion of H3-Phytol to phytanic acid and its incorporation into plasma lipid fractions in heredopathia atactica polyneuritiformis. Metab 15(8):687–693
Kitareewan S, Burka LT, Tomer KB, Parker CE, Deterding LJ, Stevens RD, Forman BM, Mais DE, Heyman RA, McMorris T, Weinberger C (1996) Phytol metabolites are circulating dietary factors that activate the nuclear receptor RXR. Mol Biol Cell 7(8):1153–1166
Koch-Henriksen N, Sorensen PS (2010) The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol 9(5):520–532
Lardizabal JA, Deedwania P (2011) Lipid-lowering therapy with statins for the primary and secondary prevention of cardiovascular disease. Cardiol Clin 29(1):87–103
Lemotte PK, Keidel S, Apfel CM (1996) Phytanic acid is a retinoid X receptor ligand. Eur J Biochem 236(1):328–333
Lim SY, Bauermeister A, Kjonaas RA, Ghosh SK (2006a) Phytol-based novel adjuvants in vaccine formulation: 2. assessment of efficacy in the induction of protective immune responses to lethal bacterial infections in mice. J Immune Based Ther Vaccines 4:5
Lim SY, Meyer M, Kjonaas RA, Ghosh SK (2006b) Phytol-based novel adjuvants in vaccine formulation: 1. assessment of safety and efficacy during stimulation of humoral and cell-mediated immune responses. J Immune Based Ther Vaccines 4:6
Lin Y, Mousa SS, Elshourbagy N, Mousa SA (2010) Current status and future directions in lipid management: emphasizing low-density lipoproteins, high-density lipoproteins, and triglycerides as targets for therapy. Vasc Vascular health Risk Manage 6:73–85
Masters-Thomas A, Bailes J, Billimoria JD, Clemens ME, Gibberd FB, Page NG (1980) Heredopathia atactica polyneuritiformis (Refsum’s disease): 1. Clinical features and dietary management. J Hum Nutr 34(4):245–250
McCarty MF (2001) The chlorophyll metabolite phytanic acid is a natural rexinoid—potential for treatment and prevention of diabetes. Med Hypotheses 56(2):217–219
McKeage K, Keating GM (2011) Fenofibrate a review of its use in dyslipidaemia. Drugs 71(14):1917–1946
Mize CE, Avigan J, Baxter JH, Fales HM, Steinberg D (1966) Metabolism of phytol-U-14C and phytanic acid-U-14C in the rat. J Lipid Res 7(5):692–697
Mukherji M, Schofield CJ, Wierzbicki AS, Jansen GA, Wanders RJ, Lloyd MD (2003) The chemical biology of branched-chain lipid metabolism. Prog Lipid Res 42(5):359–376
Nedergaard J, Cannon B (2010) The changed metabolic world with human brown adipose tissue: therapeutic visions. Cell Metab 11(4):268–272
Nordestgaard BG, Chapman MJ, Ray K, Boren J, Andreotti F, Watts GF, Ginsberg H, Amarenco P, Catapano A, Descamps OS, Fisher E, Kovanen PT, Kuivenhoven JA, Lesnik P, Masana L, Reiner Z, Taskinen MR, Tokgozoglu L, Tybjaerg-Hansen A, Conse EAS (2010) Lipoprotein(a) as a cardiovascular risk factor: current status. Eur Heart J 31(23):2844–2853
Olofsson P, Holmberg J, Tordsson J, Lu SM, Akerstrom B, Holmdahl R (2003) Positional identification of Ncf1 as a gene that regulates arthritis severity in rats. Nat Genet 33(1):25–32
Patton S, Benson AA (1966) Phytol metabolism in the bovine. Biochim Biophys Acta 125(1):22–32
Pereira RM, de Carvalho JF, Bonfa E (2009) Metabolic syndrome in rheumatological diseases. Autoimmun Rev 8(5):415–419
Refsum S (1976) Heredopathia atactica polyneurotiformis: therapeutic and pathogenetic aspects. Rivista di patologia nervosa e mentale 97(3):115–126
Schluter A, Barbera MJ, Iglesias R, Giralt M, Villarroya F (2002a) Phytanic acid, a novel activator of uncoupling protein-1 gene transcription and brown adipocyte differentiation. Biochem J 362(Pt 1):61–69
Schluter A, Giralt M, Iglesias R, Villarroya F (2002b) Phytanic acid, but not pristanic acid, mediates the positive effects of phytol derivatives on brown adipocyte differentiation. FEBS Lett 517(1–3):83–86
Scott DL, Wolfe F, Huizinga TWJ (2010) Rheumatoid arthritis. Lancet 376(9746):1094–1108
Sheng X, Murphy MJ, MacDonald TM, Wei L (2012) Effect of statins on total cholesterol concentrations and cardiovascular outcomes in patients with diabetes mellitus: a population-based cohort study. Eur J Clin Pharmacol 68(8):1201–1208
Shimizu M, Tomoo T (1994) Anti-inflammatory constituents of topically applied crude drugs. V. Constituents and anti-inflammatory effect of Aoki, Aucuba japonica Thunb. Biol Pharm Bulletin 17(5):665–667
Steinberg D, Avigan J, Mize CE, Baxter JH, Cammermeyer J, Fales HM, Highet PF (1966) Effects of dietary phytol and phytanic acid in animals. J Lipid Res 7(5):684–691
ten Brink HJ, Schor DS, Kok RM, Poll-The BT, Wanders RJ, Jakobs C (1992) Phytanic acid alpha-oxidation: accumulation of 2-hydroxyphytanic acid and absence of 2-oxophytanic acid in plasma from patients with peroxisomal disorders. J Lipid Res 33(10):1449–1457
Todd JA, Knip M, Mathieu C (2011) Strategies for the prevention of autoimmune type 1 diabetes. Diabet Med: J British Diabet Assoc 28(10):1141–1143
Van den Branden C, Vamecq J, Wybo I, Roels F (1986) Phytol and peroxisome proliferation. Pediatr Res 20(5):411–415
van den Brink DM, Wanders RJ (2006) Phytanic acid: production from phytol, its breakdown and role in human disease. Cell Mol Life Sci: CMLS 63(15):1752–1765
Verhoeven NM, Wanders RJ, Poll-The BT, Saudubray JM, Jakobs C (1998) The metabolism of phytanic acid and pristanic acid in man: a review. J Inherit Metab Dis 21(7):697–728
Vijgen GH, Bouvy ND, Teule GJ, Brans B, Schrauwen P, van Marken Lichtenbelt WD (2011) Brown adipose tissue in morbidly obese subjects. PLoS One 6(2):e17247
Werner LB, Hellgren LI, Raff M, Jensen SK, Petersen RA, Drachmann T, Tholstrup T (2011) Effect of dairy fat on plasma phytanic acid in healthy volunteers—a randomized controlled study. Lipids Health Dis 10:95
Zomer AW, van Der Burg B, Jansen GA, Wanders RJ, Poll-The BT, van Der Saag PT (2000) Pristanic acid and phytanic acid: naturally occurring ligands for the nuclear receptor peroxisome proliferator-activated receptor alpha. J Lipid Res 41(11):1801–1807
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Olofsson, P., Hultqvist, M., Hellgren, L.I., Holmdahl, R. (2014). Phytol: A Chlorophyll Component with Anti-inflammatory and Metabolic Properties. In: Jacob, C., Kirsch, G., Slusarenko, A., Winyard, P., Burkholz, T. (eds) Recent Advances in Redox Active Plant and Microbial Products. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-8953-0_13
Download citation
DOI: https://doi.org/10.1007/978-94-017-8953-0_13
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-017-8952-3
Online ISBN: 978-94-017-8953-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)